MOTS-c

Most signaling peptides are encoded in the cell nucleus. MOTS-c is different: it is encoded within the mitochondrial genome itself (the 12S rRNA region), which is why it is grouped with the small family of 'mitochondrial-derived peptides.' In the foundational paper (Lee et al., Cell Metabolism 2015), researchers associated MOTS-c with activation of AMPK — the cell's master energy sensor — and with improved insulin sensitivity in cell and mouse models, including resistance to diet-induced obesity. That AMPK link is the reason later work frames it as an 'exercise mimetic': it engages a pathway that exercise itself activates.

The most cited follow-up is Reynolds et al. (Nature Communications 2021). In mice, researchers reported that MOTS-c administration improved running capacity across young, middle-aged, and old animals, and they observed that exercise induces endogenous MOTS-c expression in human skeletal muscle — connecting the synthetic peptide to a naturally exercise-responsive system. A separate human observational study (D'Souza et al., Aging 2020) associated skeletal-muscle MOTS-c with myofiber composition in healthy aging men. These are the anchors for the longevity/endurance research interest.

Kim et al. (Cell Metabolism 2018) reported that under metabolic stress MOTS-c can translocate from the mitochondria to the nucleus and modulate stress-response gene programs, including NRF2-linked antioxidant pathways. This 'retrograde' mitochondria-to-nucleus signaling is part of why the compound draws interest beyond simple energy metabolism.

Two things are true at once. The preclinical literature is strong and replicated. And the human literature is still early and largely observational — no large randomized human trial has reproduced the running-capacity findings, and a registered human study in metabolic syndrome (ClinicalTrials.gov) remains early-phase. Researchers also note that effects in animal models are typically subtle and metabolic-context-dependent rather than dramatic, and individual response varies. None of this is dosing or use guidance; it is provided as research context only. Competition note: MOTS-c is listed by WADA (S4) and is prohibited for tested athletes — disclosed here for completeness.

Catalog format: lyophilized research material as presented on the storefront listing.

In-stock listing sizes: 10mg, 40mg.

Laboratory handling note: publications in this field typically report controlled storage, chain-of-custody documentation, and method-specific reconstitution procedures under institutional SOPs. This site does not provide dosing, administration, or protocol instructions.